Dozens in northeast England report symptoms of potentially deadly botulism after getting Botox
Health officials in the UK are investigating reports of dozens of people suffering from a potentially life-threatening condition following Botox procedures in northeastern England, as well as allegations of the illegal sale of Botox-like products.
The local trust of the UK's National Health Service (NHS) in the county of Durham put out an alert on June 13 about several people seeking medical attention after having adverse reactions to cosmetic procedures involving Botox.
Since the incident first came to light last week, 28 individuals have reported symptoms of botulism after receiving cosmetic procedures, the UK Health and Security Agency (UKHSA) told CNN in a statement Friday.
Botulism is a life-threatening condition caused by toxins made by Clostridium botulinum bacteria that attack the nervous system and cause paralysis.
'These toxins (but not the bacteria) are the active ingredient in Botox and similar products,' Dr. Joanne Darke, a consultant in health protection at the UKHSA, said in the statement, adding that it is 'important to go to a licensed practitioner.'
Iatrogenic botulism is a type of botulism that occurs when too much of the cosmetic form, Botox, is injected into a muscle. Botox is a leading cosmetic treatment for wrinkles, as well as for medical conditions such as migraines and excessive sweating.
The UKHSA said the reactions reported have included symptoms of severe drooping of the upper eyelids, double vision, difficulty swallowing, slurred speech and lethargy.
Other symptoms of botulism can include facial muscle weakness.
Botulism requires immediate medical attention and is fatal in 5-10% of cases, according to the NHS website.
While most people make a full recovery with treatment, which typically involves getting injections with antitoxins, without quick care, paralysis can spread to muscles used to control breathing.
While investigations into the cause of the cases are ongoing, the UKHSA said that 'evidence so far does not suggest that the product used has been contaminated. Symptoms are being reported a few days up to four weeks after injection.'
'The practitioners associated with most of the reported cases are no longer carrying out these procedures,' said Dr. Simon Howard, a consultant in health protection at the UKHSA, in the statement.
'However, that does not mean that we may not see more cases as symptoms can take up to four weeks to develop although we are now seeing the number of cases coming forward decreasing which is encouraging news,' he continued.
Howard advised people to ensure they take precautions when seeking aesthetic procedures and advised anyone with symptoms to seek medical attention.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) told CNN Friday that it is investigating 'allegations surrounding the illegal sale and supply of Botox-type products in the North-East, and want to reassure the public that we take such claims very seriously.'
The agency encouraged people in the UK who believe they have had side effects from medicine or received falsified stock to report it to its Yellow Card program.
'Our Criminal Enforcement Unit works hard to identify those involved in the illegal trade in medicines and takes robust enforcement action where necessary. This can include criminal prosecution,' Dr. Alison Cave, chief safety officer at MHRA, said in the statement.
'Botulinum toxin (Botox) is a prescription-only medicine and should only be available in the UK under the supervision of a doctor or other qualified healthcare professional,' she continued.
In the United States, a growing cluster of botulism cases linked to cosmetic injections was reported in Massachusetts earlier this month. The state's Department of Health said it was investigating 10 cases of suspected iatrogenic botulism all associated with Botox procedures performed at one spa, Rodrigo Beauty.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Kate Middleton Shares New Message After Dropping Out of Royal Ascot Appearance
Kate Middleton has written a poignant message to children's hospices, saying it was an "immense privilege" to see their work The Princess of Wales, 43, praised them for lifting the spirits of children and families "through life, death and beyond" Her June 20 message, as Children's Hospice Week draws to an end, came six months after she took on the role of patron to a hospice in South WalesKate Middleton is showing her support for kids' hospices in a poignant week. In a new message issued on Friday, June 20, the Princess of Wales praised how hospices 'lift the spirits' and support seriously ill children and their families through 'life, death and beyond.' She said it was an 'immense privilege' seeing the work up close of two hospices, with East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice, during her visits as their patron. It came in a week when Princess Kate, 43, dropped out of an expected visit to the Royal Ascot race meeting on Wednesday. Kate is still managing her return to public-facing duties amid her recovery from cancer treatment. In her message on June 20, Kate wrote, 'No parent expects to hear that their child has a serious health condition that could shorten their life. Sadly, this is the reality faced by thousands of families across the country, leaving them heartbroken, fearful of the future and often desperately isolated." 'Being able to access the support of one of the U.K.'s 54 children's hospices means they don't have to face that future alone," she added. 'As Patron of East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice in South Wales, I have the immense privilege of seeing for myself the extraordinary work of our children's hospices," she said. "Lifting spirits through laughter, fun and play, as well as listening, holding, caring and sharing, they support children and families through life, death and beyond." "This Children's Hospice Week, I hope you will join me in celebrating the life-changing work they do and thanking them for the vital care they provide to children and families experiencing the most challenging times," Kate concluded. Support for children's hospices has been an ever-present part of Princess Kate's public work since she started in public life soon after marrying Prince William in 2011. She has also visited hospices around the world during her overseas tours. During Children's Hospice Week, which ends on June 22, the charity Together for Short Lives brings together the vital services to celebrate the incredible work they do for seriously ill children and their families. Kate made her first visit to Tŷ Hafan in January, spending more time than she was scheduled, crouching down, talking to youngsters and their families and joining in with the games. Tŷ Hafan — which means "Haven House" in Welsh — is located in Sully, South Wales, and was built with the support of Prince William's late mother, Princess Diana. Tracy Jones, the director of family well-being services who showed Kate around, said on the day of the visit in January, 'She immediately gravitated to the children and families — she spent quality time talking to every child and their parents.' 'It's been the most inspiring visit,' Jones added. 'She crouched down and was straightaway on the level of the children. If they were in a wheelchair, she crouched at that level. If they were on the floor, she would be at the level,' she continues. 'We were seriously impressed with how she could stay in a crouch, as it's not that comfortable!" "She instinctively seemed to know where to touch a child that was going to provide the connection, but not cause any distress or startle a child. She was looking at the children, even if she was talking to the parent. It's what we do, as we're used to working with children who are nonverbal," she added. Nick Carroll, CEO of Together for Short Lives, praised Kate's "ongoing support for Children's Hospice Week over many years [that] has helped to raise much-needed awareness of the life-changing work children's hospices do, every day of the year." "Their extraordinary lifeline care for children with life-limiting and life-threatening illnesses enables families to make the most of their lives together, whether that's for years, months or only hours," he said. 'Together with all the children's hospices, we thank the Princess of Wales for her invaluable contribution.' Irfon Rees, Chief Executive of Tŷ Hafan Children's Hospice, said in a statement on June 20, 'Her Royal Highness is clearly profoundly committed to the needs of children and young people, and in January, during her first visit to our hospice as our patron, her kindness and empathy were evident." 'Having HRH's support during Children's Hospice Week means that not only can we take time to celebrate the difference that children's hospices, including Tŷ Hafan, have made to the lives of so many families, but that we can also remind people of the importance of supporting their local children's hospice so that no family has to live their child's short life alone.' Can't get enough of PEOPLE's Royals coverage? to get the latest updates on Kate Middleton, Meghan Markle and more! Kevin Clements, Chief Executive of EACH, based in the area close to the Wales family's country home, Anmer Hall, in Norfolk, added, 'We're so incredibly grateful for The Princess' invaluable contribution as our dedicated Royal Patron. Her ongoing support and vast profile have projected our charity onto the global stage, and this latest message is a perfect way to mark Children's Hospice Week." 'It's a great opportunity to shine a light on the work of children's hospices generally, as well as giving us an opportunity to raise awareness and remind everyone of the need for public support, given we rely on donations for the majority of our income.' Read the original article on People
Yahoo
an hour ago
- Yahoo
MPs may have passed the assisted dying bill, but the debate is just beginning
Now that the assisted dying bill has passed its momentous third reading in the House of Commons, it may seem like legalisation in England and Wales is a done deal. But despite this significant milestone, the bill is not yet law and its journey through the House of Lords is far from a formality. While the terminally ill adults (end of life) bill is now closer than ever to becoming law, both the Commons and the Lords must agree on its final wording. And just like in the Commons, there are passionate supporters and vocal opponents in the Lords. Peers are expected to focus their attention on a number of outstanding, and controversial, issues. One of the biggest concerns that surfaced during both the report stage and today's third reading relates to the speed and process of drafting the legislation. Because this is a private member's bill, introduced by Labour MP Kim Leadbeater, it was subject to strict timelines. Leadbeater had just 85 days to work with legal drafters and set out a policy framework before the bill was published ahead of its second reading in November 2024. Despite this, the democracy-supporting charity the Hansard Society has noted that the bill is 'among the most heavily scrutinised in recent times', and it could ultimately receive up to 200 hours of parliamentary debate, especially now that it has moved to the Lords. Still, the fast turnaround meant that many important decisions, such as what medications will be approved for use in assisted dying, have been left for the secretary of state to determine later through what's known as delegated legislation (secondary laws made without a full parliamentary vote). One area likely to receive particular scrutiny is the bill's inclusion of so-called 'Henry VIII clauses'. These are controversial powers that allow ministers to make changes to existing primary legislation, effectively altering acts of parliament without needing a new law. A key example is clause 38 that would let ministers revise the NHS Act 2006 to formally include assisted dying within NHS services. Several amendments aimed at strengthening the bill's safeguards were supported during the Commons stages. These included the introduction of independent advocates, a new disability advisory board, and additional protections for people with learning disabilities, mental health conditions, or autism. An amendment from Labour MP Naz Shah was also supported at the third reading, ensuring that a person who chooses to stop eating and drinking will not automatically be considered terminally ill. This is a protection designed to prevent the system being used inappropriately. Yet despite these measures, concerns remain. Critics worry about the risk of coercion, both from others and self imposed. There is particular unease about people feeling pressured to choose assisted dying because they consider themselves a burden. Questions have also been raised about whether those with conditions like anorexia might qualify for assisted dying under the current wording of the bill. Even with the new safeguards, including mandatory training for doctors to detect coercion and assess mental capacity, many feel the bill needs tighter definitions and clearer criteria to protect the most vulnerable. The impact on palliative and end-of-life care continues to be a major point of debate. Today, MPs backed an amendment from Liberal Democrat MP Munira Wilson that would require the government to assess the state of palliative care services within one year of the law being enacted. Peers in the House of Lords may push further on this issue. Some may argue that before a person can request assisted dying, they should first be referred to a palliative care specialist to fully understand their options. Others may want the law to spell out more clearly who is qualified to assess these requests. Another key question is who should provide assisted dying services. The British Medical Association has previously suggested a model where assisted dying operates outside the core NHS system. This would be a kind of parallel service overseen by the health secretary but delivered by independent providers. This would be similar to how early medical abortions are offered in some parts of the UK. Time is tight in the Lords, so peers will probably focus on a few high priority areas. Any amendments will need to be proposed, debated and approved quickly if the bill is to continue progressing this session. Even if the bill passes, it includes a four year implementation period to allow for the development of more detailed policies, including training for professionals, protocols for medication and clearer guidance on safeguarding. The passing of the bill in the Commons is historic. But the national conversation on assisted dying is not over. And the next phase will determine how this sensitive and deeply personal issue is handled in practice. This article is republished from The Conversation under a Creative Commons license. Read the original article. Suzanne Ost has previously received funding from the AHRC for her assisted dying research. Nancy Preston receives funding from Horizon Europe, Horizon 2020 and the NIHR
Medscape
2 hours ago
- Medscape
Cancer Concerns Spark Caution Over Weight Loss Injections
Cancer patients should seek medical advice before using weight loss injections, a leading UK charity has said. Macmillan Cancer Support urged patients not to view these drugs as 'quick fixes', following a rise in helpline queries over whether they should take them. Obesity is a well-established risk factor for several cancer types and is linked to worse outcomes in patients who already have a cancer diagnosis. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have seen rapid uptake for weight loss. Their popularity has helped fuel speculation that they could reduce the risk of cancer or improve outcomes in people with obesity-related cancers. Mixed Findings on Cancer Risk and Benefits A study published in The Lancet eClinical Medicine in May compared outcomes in patients treated with GLP-1 RAs versus bariatric surgery. The research involved 3178 age- and BMI-matched pairs in Israel. Despite surgery achieving greater weight loss, both groups had similar rates of obesity-related cancers. The researchers suggested that there could be additional pathways beyond weight loss through which GLP-1RAs might lower cancer risk, for example by reducing inflammation. Other experts have proposed additional pathways, including enhanced immune responses, improved insulin sensitivity, hormonal modulation, and changes to gut microbiome. As a result of the study, clinical trials of GLP-1RAs as potential anti-cancer agents are planned. Potential Risks: Thyroid and Pancreatic Cancer Some studies have suggested that GLP-1RAs carry a minor increase in the risk of thyroid cancer, which is one of the 13 cancers known to be linked with obesity. Some GLP-1RAs now carry warnings about this potential link, although the evidence is conflicting. One meta-analysis of 64 studies by Italian researchers, published in March 2024, found a significant increase overall thyroid cancer risk. However, the data did not show a significant rise in papillary or medullary thyroid cancer when analysed separately. The researchers concluded that GLP-1RA treatment could be associated with a moderate increase in the relative risk of thyroid cancer, though the absolute risk remained small. They called for longer-term studies to clarify the link. In contrast, a Scandinavian cohort study published in April found no substantial increase in thyroid cancer risk over an average follow-up of 3.9 years. The authors said the findings did not rule out a slight increase but suggested no more than a 31% relative risk rise. Similar concerns have been raised about a theoretical risk of pancreatic cancer, but no conclusive evidence has been found. Macmillan Helpline Sees Spike in Inquiries Following recent media coverage, Macmillan Cancer Support reported a surge in calls and messages about weight loss medications, including the potential risk to people with thyroid cancer. Dr Owen Carter, Macmillan's national clinical adviser, said in a press release that there had been "a noticeable increase" in calls to the charity's free support line, alongside "a flurry of messages" on its peer-to-peer online community platform. In response, the charity has published updated information about weight loss injections and cancer on its website. Carter said that some callers were concerned about taking weight loss drugs while undergoing cancer treatments such as chemotherapy or hormone therapy. While there is currently not enough evidence, "we do know that these drugs may affect how other drugs are absorbed by your body," he said. "This may include some anti-cancer drugs." Weight Loss Before Surgery and Pre-habilitation Other patients have asked whether weight loss medication is safe to take before surgery for cancer. "Understandably, people are keen to do what they can to get ready for cancer treatment," Carter said. Healthcare professionals often recommend pre-habilitation to help patients prepare for treatment by improving their fitness and overall health. However, Carter warned against unprescribed use of weight loss injections as 'quick fixes'. 'We simply do not know enough about the long-term impact of these weight loss medications to recommend them if they're not prescribed by a specialist,' he said. Carter also emphasised the importance of making lifestyle changes alongside use of medications. "We know that eating well and staying as active as possible are proven to help people feel better, increase their energy levels, and strengthen their immune systems, which can help them to manage their weight and cope better with cancer treatment", he said. Risks of Unregulated Online Purchases Macmillan also raised concerns about people buying GLP-1 RAs online from unregulated sources. Some patients are reported to have experienced severe side effects from counterfeit medicines. The charity urged people to speak to their GP before taking weight loss drugs. Macmillan noted that potential side-effects of GLP-1RAs include nausea and vomiting, abdominal pain, diarrhoea or constipation, and fatigue. They can also reduce the effectiveness of oral contraceptives. There have been reports of unplanned pregnancies occurring while taking these drugs, which may be particularly hazardous in cancer patients, as some cancer treatments are teratogenic.
